Tocilizumab

Tocilizumab (Anti-Human IL6R, Humanized Antibody) is an anti-human interleukin-6 receptor (IL-6R) neutralizing antibody, prevents binding of IL-6 to the IL-6R, thereby inhibiting both classic and trans-signaling. Tocilizumab (Anti-Human IL6R, Humanized Antibody) can be used for the treatment of rheumatoid arthritis. Tocilizumab is remarkablely effective for the study of severe COVID-19 (coronavirus disease).
Read more
€0.00 (tax incl.)
Reference:
HY-P9917
Product Details
HY-P9917

Data sheet

Size
Multiple sizes
Reactivity
Interleukin Related
Application
Cancer-Kinase/protease
CAS
375823-41-9

Menu

Settings